A Phase I Dose-Finding Trial of Recombinant Interleukin-21 and Rituximab in Relapsed and Refractory Low Grade B-cell Lymphoproliferative Disorders

出版年份 2012 全文链接

标题

作者

关键词

出版物

Volume 18, Issue 20, Pages 5752-5760

出版商

American Association for Cancer Research (AACR)

发表日期

2012-08-15

DOI

10.1158/1078-0432.ccr-12-0456

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discuss science. Find collaborators. Network.

Join a conversation